Miyawaki, Taichi
Kenmotsu, Hirotsugu http://orcid.org/0000-0003-0590-9259
Harada, Hideyuki
Ohde, Yasuhisa
Chiba, Yasutaka
Haratani, Koji
Okimoto, Tamio
Sakamoto, Tomohiro
Wakuda, Kazushige
Ito, Kentaro
Uemura, Takehiro
Sakata, Shinya
Kogure, Yoshihito
Nishimura, Yasumasa
Nakagawa, Kazuhiko
Yamamoto, Nobuyuki
Article History
Received: 4 February 2021
Accepted: 8 October 2021
First Online: 18 October 2021
Declarations
:
: The WJOG 11118 L study is being conducted in compliance with the principles of the Declaration of Helsinki, and it was approved by the central review board of Shizuoka Cancer center. Written informed consent is obtained from all participants.
: Not applicable.
: Dr. Kenmotsu reports grants and personal fees from AstraZeneca K.K., grants and personal fees from Chugai Pharmaceutical Co, Ltd., personal fees from Ono Pharmaceutical Co, Ltd., grants and personal fees from Boehringer Ingelheim, personal fees from Eli Lilly K. K, personal fees from Kyowa Hakko Kirin Co., Ltd., personal fees from Bristol-Myers Squibb, personal fees from MSD, grants and personal fees from Novartis Pharma K.K., grants and personal fees from Daiichi-Sankyo Co., Ltd., personal fees from Pfizer, and personal fees from Taiho Pharma, outside the submitted work.Dr. Harada reports personal fees from Daiichi Sankyo pharmaceutical Co., during the conduct of the study; personal fees from Daiichi Sankyo pharmaceutical co., personal fees from AstraZneca pharmaceutical co., personal fees from Brain labo co., personal fees from Chugai Pharmaceutical Co., grants from Japan Agency for Medical Research and Development, grants from The National Cancer Center Research and Development fund, outside the submitted work.Dr. Chiba reports personal fees from Chugai Pharmaceutical Co., Ltd., outside the submitted work.Dr. Haratani reports personal fees from AS ONE Corporation, grants and personal fees from AstraZeneca K.K., personal fees from Bristol-Myers Squibb Co. Ltd., personal fees from Chugai Pharmaceutical Co. Ltd., grants and personal fees from MSD K.K. 2018/11, personal fees from Ono Pharmaceutical Co. Ltd., and personal fees from Pfizer Japan Inc., outside the submitted work.Dr. Sakamoto reports personal fees from AstraZeneca K.K., personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Merck KGaA, personal fees from Eli Lilly Japan K.K., personal fees from Novartis Pharma K.K., and personal fees from Kyowa Kirin Co., Ltd., outside the submitted work.Dr. Wakuda reports grants and personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Taiho Pharmaceutical, personal fees from Boehringer Ingelheim, personal fees from Eli Lilly K.K., personal fees from Ono Pharmaceutical, personal fees from MSD, grants from Novartis, grants from AbbVie, grants and personal fees from AstraZeneca, outside the submitted work.Dr. Ito reports personal fees from Boehringer Ingelheim, personal fees from AstraZeneca, personal fees from Pfizer, Eli Lilly, personal fees from Chugai Pharmaceutical, personal fees from Merk Sharp & Dohme (MSD), personal fees from Ono Pharmaceutical, personal fees from Taiho Pharmaceutical, during the conduct of the study.Dr. Uemura reports personal fees from Chugai Pharmaceutical Co., Ltd., outside the submitted work.Dr. Kogure reports personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co, Ltd., Eli Lilly K. K, and Boehringer Ingelheim., grants and personal fees from MSD, which are unrelated to the submitted work.Dr. Nakagawa reports grants and personal fees from AstraZeneca K.K., grants and personal fees from Astellas Pharma Inc., grants and personal fees from MSD K.K., grants, personal fees and other from Ono Pharmaceutical Co., Ltd., grants and personal fees from Nippon Boehringer Ingelheim Co., Ltd., grants and personal fees from Novartis Pharma K.K., grants, personal fees and other from Pfizer Japan Inc., grants and personal fees from Bristol-Myers Squibb Company, grants, personal fees and other from Eli Lilly Japan K.K., grants and personal fees from Chugai Pharmaceutical Co., Ltd., grants and personal fees from Daiichi Sankyo Co., Ltd., grants and personal fees from Merck Serono Co., Ltd./ Merck Biopharma Co., Ltd., during the conduct of the study; personal fees from Clinical Trial Co., Ltd., personal fees from MEDICUS SHUPPAN, Publishers Co., Ltd., personal fees from Care Net, Inc., personal fees from Reno. Medical K.K., personal fees and other from KYORIN Pharmaceutical Co., Ltd., personal fees from Medical Review Co., Ltd., personal fees from Roche Diagnostics K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Medical Mobile Communications co., Ltd., personal fees from 3H Clinical Trial Inc., personal fees from Nichi-Iko Pharmaceutical Co., Ltd., grants, personal fees and other from Takeda Pharmaceutical Co., Ltd., grants and personal fees from Taiho Pharmaceutical Co., Ltd., grants and personal fees from SymBio Pharmaceuticals Limited., personal fees from NANZANDO Co., Ltd., personal fees from YODOSHA CO., LTD., personal fees from Nikkei Business Publications, Inc., personal fees from Thermo Fisher Scientific K.K., personal fees from YOMIURI TELECASTING CORPORATION., personal fees from Nippon Kayaku Co., Ltd., grants and personal fees from AbbVie Inc., grants from inVentiv Health Japan, grants from ICON Japan K.K., grants from GRITSONE ONCOLOGY.INC, grants from PAREXEL International Corp., grants from Kissei Pharmaceutical Co., Ltd., grants from EPS Corporation., grants from Syneos Health., grants from Pfizer R&D Japan G.K., grants from A2 Healthcare Corp., grants from Quintiles Inc. / IQVIA Services JAPAN K.K., grants from EP-CRSU CO., LTD., grants from Linical Co., Ltd., grants from Eisai Co., Ltd., grants from CMIC Shift Zero K.K., grants from Kyowa Hakko Kirin Co., Ltd., grants from Bayer Yakuhin, Ltd., grants from EPS International Co., Ltd.,., grants from Otsuka Pharmaceutical Co., Ltd., outside the submitted work.Dr. Yamamoto reports grants and personal fees from MSD K.K., grants and personal fees from AstraZeneca, grants and personal fees from ONO PHARMACEUTICAL CO., LTD., personal fees from Thermo Fisher Scientific, grants and personal fees from Daiichi Sankyo Co., Ltd., grants and personal fees from TAIHO PHARMACEUTICAL CO., LTD., grants and personal fees from Takeda Pharmaceutical CO., LTD., grants and personal fees from Chugai Pharmaceutical Co., LTD., grants and personal fees from Eli Lilly Japan K.K., grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, grants and personal fees from Pfizer Inc., personal fees from Bristol-Myers Squibb, personal fees from Life Technologies Japan Ltd., personal fees from NIPPON KAYAKU, personal fees from Merk Biopharma, grants from Astellas Pharma Inc., grants from TSUMURA & CO., grants from SHIONOGI Co., Ltd., grants from AbbVie G.K., grants from Amgen Inc., grants from KYORIN Pharmaceutical Co., Ltd., grants from Eisai Co., Ltd., grants from TERUMO CORPORATION, grants from Toppan Printing Co., Ltd., grants from TOSOH, outside the submitted work.